Erratum to “Immediate-type hypersensitivity and other clinical reactions in volunteers immunized with a synthetic multi-antigen peptide vaccine (PfCS-MAP1NYU) against Plasmodium falciparum” [Vaccine 21 (2003) 269–280]

Erratum to “Immediate-type hypersensitivity and other clinical reactions in volunteers immunized with a synthetic multi-antigen peptide vaccine (PfCS-MAP1NYU) against Plasmodium falciparum” [Vaccine 21 (2003) 269–280] Robert Edelman a,∗, Steven S. Wasserman a, James G. Kublin a, Sacared A. Bodison b, Elizabeth H. Nardin c, Giane A. Oliveira c, Sobia Ansari c, Carter L. Diggs d, Oscar L. Kashala e, Barbara J. Schrneckpeper f, Robert G. Hamilton g a Department of Medicine, Center for Vaccine Development, University of Maryland School of Medicine, Room 480, 685 West Baltimore Street, Baltimore, MD 21201, USA b University Health Center, University of Maryland, College Park, MD, USA c Department of Medical and Molecular Parasitology, New York University School of Medicine, New York, NY, USA d Malaria Vaccine Development Program, Agency for International Development, Washington, DC, USA e Aquila Biopharmaceuticals Inc., Framingham, MA, USA f Immunogenetics Laboratories, Johns Hopkins University School of Medicine, Baltimore, MD, USA g Reference Laboratory for Dermatology, Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, MD, USA